AGEN
Price
$4.83
Change
+$0.27 (+5.91%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
124.75M
CRSP
Price
$48.52
Change
-$0.12 (-0.25%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
4.19B
41 days until earnings call
Interact to see
Advertisement

AGEN vs CRSP

Header iconAGEN vs CRSP Comparison
Open Charts AGEN vs CRSPBanner chart's image
Agenus
Price$4.83
Change+$0.27 (+5.91%)
Volume$9.21K
Capitalization124.75M
CRISPR Therapeutics AG
Price$48.52
Change-$0.12 (-0.25%)
Volume$54.13K
Capitalization4.19B
AGEN vs CRSP Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. CRSP commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Hold and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (AGEN: $4.57 vs. CRSP: $48.64)
Brand notoriety: AGEN and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 57% vs. CRSP: 232%
Market capitalization -- AGEN: $124.75M vs. CRSP: $4.19B
AGEN [@Biotechnology] is valued at $124.75M. CRSP’s [@Biotechnology] market capitalization is $4.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGEN and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а -4.79% price change this week, while CRSP (@Biotechnology) price change was +6.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.19B) has a higher market cap than AGEN($125M). AGEN YTD gains are higher at: 66.788 vs. CRSP (23.577). AGEN has higher annual earnings (EBITDA): -81.06M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. AGEN (18.5M). AGEN has less debt than CRSP: AGEN (92M) vs CRSP (219M). AGEN has higher revenues than CRSP: AGEN (99.5M) vs CRSP (35M).
AGENCRSPAGEN / CRSP
Capitalization125M4.19B3%
EBITDA-81.06M-455.24M18%
Gain YTD66.78823.577283%
P/E Ratio0.16N/A-
Revenue99.5M35M284%
Total Cash18.5M1.86B1%
Total Debt92M219M42%
FUNDAMENTALS RATINGS
AGEN vs CRSP: Fundamental Ratings
AGEN
CRSP
OUTLOOK RATING
1..100
7525
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (67) in the Biotechnology industry is in the same range as AGEN (97). This means that CRSP’s stock grew similarly to AGEN’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that CRSP’s stock grew similarly to AGEN’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as AGEN (100). This means that CRSP’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (35) in the Biotechnology industry is in the same range as CRSP (41). This means that AGEN’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (80) in the Biotechnology industry is in the same range as AGEN (100). This means that CRSP’s stock grew similarly to AGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 20 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UGE18.580.19
+1.02%
ProShares Ultra Consumer Staples
VSMV49.280.33
+0.68%
VictoryShares US Mult-Fctr Mnmm Vltl ETF
MORT10.560.07
+0.67%
VanEck Mortgage REIT Income ETF
PHK4.800.02
+0.42%
PIMCO High Income Fund
DIHP29.490.09
+0.31%
Dimensional International High Pbly ETF